BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35222010)

  • 1. Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2021; 12():794254. PubMed ID: 35222010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2019; 10():1423. PubMed ID: 31849671
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
    Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
    Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).
    Luethi D; Trachsel D; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):141-148. PubMed ID: 28720478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
    Luethi D; Widmer R; Trachsel D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2019 Jul; 855():103-111. PubMed ID: 31063768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Bulky
    Soares BA; Yempala T; Martínez-Afani D; Acevedo-Fuentes W; Brea J; Loza MI; Cimadevila M; Cassels BK
    ACS Chem Neurosci; 2024 Feb; 15(3):608-616. PubMed ID: 38241462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG
    J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
    Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
    Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
    Pertz HH; Brown AM; Gager TL; Kaumann AJ
    J Pharm Pharmacol; 1999 Mar; 51(3):319-30. PubMed ID: 10344634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT
    Hemanth P; Nistala P; Nguyen VT; Eltit JM; Glennon RA; Dukat M
    Front Pharmacol; 2023; 14():1101290. PubMed ID: 36762110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.
    Kolaczynska KE; Ducret P; Trachsel D; Hoener MC; Liechti ME; Luethi D
    Eur Neuropsychopharmacol; 2022 Jun; 59():9-22. PubMed ID: 35378384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.
    Halberstadt AL; Chatha M; Chapman SJ; Brandt SD
    J Psychopharmacol; 2019 Mar; 33(3):406-414. PubMed ID: 30789291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
    Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL
    ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.